A novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body

M J Potchoiba1, T G Tensfeldt, M R Nocerini

  • 1Pfizer Inc, Central Research, Department of Drug Metabolism, Groton, Connecticut.